Portfolio
Aujourd’hui un projet : demain un traitement
S’associer à IRICoR, c’est tirer parti de NOTRE expertise, de NOS ressources et de NOTRE réseau pour accélérer VOS projets de découverte de médicaments, réduire les risques et améliorer les chances de réussite de la mise sur le marché.
En partenariat
| indication | découverte | hit id | h2l | lead opt | ind enabling | Phase clinique | partenaires |
|---|---|---|---|---|---|---|---|
|
ex vivo cell expansion Cell transplant, Small molecule (UM-171) |
Phase 2 |
|
|||||
|
PAR4 Thrombosis, Small molecule (UDM-003183, now BMS-986141) |
Phase 2 |
 |
|||||
|
PAR4 Thrombosis, Small molecule (UDM-002985, now BMS-986120) |
Phase 1 |
|
|||||
|
Undisclosed #1 Solid Tumors, Small molecule |
 |
||||||
|
Tumor Specific Antigens Liquid and Solid Tumors, Therapeutic Cancer Vaccines |
 |
||||||
|
Undisclosed GPCR CV/HF, Small molecule |
 |
||||||
|
Melanocortin-4 receptor (MC4R) pharmacochaperone Metabolic disorder, Small molecule |
 |
||||||
|
Undisclosed #2 Solid tumors, Small molecule |
|
||||||
|
Undisclosed GPCR IPF, Small molecule |
|
||||||
|
ETC1 Leukemia and solid tumors, Small molecule |
 |
||||||
|
CoREST1 degrader Oncology, Small molecule |
|
||||||
|
CyclinK degrader Oncology, Small molecule |
|
||||||
|
Undisclosed degrader Aging (epigenetics), Small molecule |
|
Opportunités de partenariat
| Indication | Discovery | Hit ID | H2L | Lead Opt | IND Enabling | Clinical phase | Academic Partner |
|---|---|---|---|---|---|---|---|
|
YES/SRC Dual kinase inhibitor Solid tumors, Small molecule |
 |
||||||
|
elF4A inhibitor Breast cancer and Solid tumors, Small molecule |
 |
||||||
|
Proteasome inhibitors Pediatric AML, Small molecule |
|
||||||
|
SLAM7 Multiple Myeloma, mAb |
 |
||||||
|
mKEAP1/NRF2 inhibitor Chemoresistance, Small molecule |
 |
||||||
|
Neuraminidase Idiopathic Thrombocytopenic Purpura (ITP), Small molecule |
 |
||||||
|
ATG5 Metabolic Fitness Cell therapy, CAR-T |
 |
||||||
|
Undisclosed TSA AML, Monoclonal antibody |
|
||||||
|
ERK3/4 Solid tumors, Small molecule |
|
||||||
|
Undisclosed Solid tumors, Antibody drug conjugate |
|
||||||
|
Undisclosed MAPK related target #1 Solid tumors, Small molecule |
|
||||||
|
Undisclosed MAPK related target #2 Solid tumors, Small molecule |
|
Plateformes de découverte de médicaments / Outils
| Projects | Discovery | Validation -POC | In operation – Active-Functional – InForce | Commercialization | Partner |
|---|---|---|---|---|---|
|
Biosenseurs BRET Drug Discovery Platform, BRET Biosensor |
|
||||
|
Chimiothèques DEL Drug Discovery Platform, DNA Encoded Library (DEL) |
|||||
|
Biosenseurs Multiplex Drug Discovery Platform, Biosensor Multiplexing Technology |
|
